Novo Nordisk A/S:
Novo Nordisk – major shareholder announcement Bagsværd, Denmark, 7 June 2022 – Novo Nordisk today announced that the company has been...
Day: June 7, 2022
MetasTx LLC Raises Funds, Engages Manufacturing Partner, And Advances Phase One Development
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC is driven to create novel therapeutics to treat and...
Skye Bioscience Expands Cannabinoid Pharmaceutical Innovation Program with Leading Cannabinoid Medicinal Chemistry Groups
New collaborations focused on building library of novel cannabinoid derivatives and small molecules capable of modulating endocannabinoid system San Diego,...
ASLAN Pharmaceuticals Initiates Scientific Collaboration to Investigate the Distinct Role of IL-13 Receptor Signaling in Atopic Dermatitis
MENLO PARK, Calif. and SINGAPORE, June 07, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ: ASLN), a clinical-stage, immunology-focused biopharmaceutical company...
Court Sanction of the Scheme of Arrangement
Acacia Pharma Group PLC THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AND REGULATED INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE...
Athira Pharma Announces Formation of Scientific Advisory Board Comprised of Renowned Leaders in Neurology Research
BOTHELL, Wash., June 07, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on...
BioXcel Therapeutics to Participate at Two Upcoming Investor Conferences
NEW HAVEN, Conn., June 07, 2022 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a commercial-stage biopharmaceutical company utilizing artificial...
Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer
TUEBINGEN, Germany and HOUSTON and CAMBRIDGE, Mass., June 07, 2022 (GLOBE NEWSWIRE) -- Immatics N.V. (Nasdaq: IMTX, “Immatics”), a clinical-stage...
Apellis and Sobi Announce First Patient Dosed in Phase 3 VALIANT Study of Pegcetacoplan for IC-MPGN and C3G, Rare Kidney Diseases with High Unmet Medical Need
WALTHAM, Mass. and STOCKHOLM, Sweden, June 07, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi® (STO:SOBI) today...
Nova Mentis Receives Controlled Substances Export Approval From The U.S. DEA For The Company’s Proprietary Psilocybin Drug NM 1001
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)...
CORRECTION FROM SOURCE: Ayujoy Herbals Ltd. and Anthea, Inc. Announce Product Sourcing and Marketing Collaboration
This document corrects and replaces the press release that was issued on May 31, 2022 8:00 AM EST. The error...
Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO
Seasoned Leader Brings Deep Knowledge of US Biotech Market to AwaknToronto, Ontario--(Newsfile Corp. - June 7, 2022) - Awakn Life...
Bloom Health Partners Launches $2 Million Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2022) - Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom"...
CarePort®, Powered by WellSky® Introduces New Predictive Analytics to Power Informed Hospital Discharge Decisions
New proprietary algorithms evaluate appropriate post-acute level of care and risk of readmission to achieve successful post-acute outcomes BOSTON--(BUSINESS WIRE)--CarePort,...
MedTech Innovator Announces Top 50 Startups Selected for the 2022 Cohort in Tenth Year of World’s Largest MedTech Accelerator Program
2022 Cohort Includes Medical Device, Diagnostics and Digital Health Startups From Across the Globe Developing Innovative Technologies to Improve Patient...
First Global Regulatory Standards for “Single-Use” Medical Device Reprocessing and Remanufacturing Published by the Association of Medical Device Reprocessors
WASHINGTON & BERLIN--(BUSINESS WIRE)--When health systems and hospitals use regulated reprocessed “single-use” devices, they reduce procedure costs without compromising patient...
AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions Partnership
NEW YORK--(BUSINESS WIRE)--#AI--Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment for oncology,...
Compulink and Phreesia Partner to Help Practices Increase Efficiency and Profitability with an Integrated Intake Solution
NEWBURY PARK, Calif. & RALEIGH, N.C.--(BUSINESS WIRE)--Compulink Healthcare Solutions, a leader in specialty-specific all-in-one EHR solutions; and Phreesia, a leader...
R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
Gaining new market segments in clinical diagnostics – globally unique position as system supplier in laboratory diagnostics sector Darmstadt, June...